FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas (Q42020999)

15 October 2017

FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas (English)

1 reference

15 October 2017

0 references

1 reference

1 reference

2

1 reference

15 October 2017

Mann B

1

1 reference

15 October 2017

Böhm C

3

1 reference

15 October 2017

Hanski ML

4

1 reference

15 October 2017

Foss HD

5

1 reference

15 October 2017

Demel G

6

1 reference

15 October 2017

Trojanek B

7

1 reference

15 October 2017

Schmidt-Wolf I

8

1 reference

15 October 2017

Stein H

9

1 reference

15 October 2017

Riecken EO

10

1 reference

15 October 2017

Buhr HJ

11

1 reference

15 October 2017

Hanski C

12

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

British Journal of Cancer

15 October 2017

1 reference

15 October 2017

79

1 reference

15 October 2017

1262-1269

1 reference

15 October 2017

7-8

1 reference

describes a project that uses

15 October 2017

Troja 1

0 references

Troja 2

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690202

0 references

cites work

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Human lung carcinomas express Fas ligand.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Memory T-lymphocytes are the main population of tumor-infiltrating lymphocytes obtained from human primary liver tumors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362258

A rapid and simple procedure for dissociation of tumor tissue from the human colon

17 August 2018

1 reference

12 December 2020

A role for CD95 ligand in preventing graft rejection

1 reference

12 December 2020

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

12 December 2020

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

12 December 2020

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

12 December 2020

Antitumor effect of locally produced CD95 ligand

1 reference

12 December 2020

Gene transfer of Fas ligand induces tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690202

7 January 2021

Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690202

7 January 2021

Detection of cell specific cluster determinant expression by reverse transcriptase polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690202

7 January 2021

Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690202

7 January 2021

Fas ligand—cought between scylla and charybdis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690202

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690202

1 reference

15 October 2017

1 reference

15 October 2017

1 reference

D9DAAF8C097220B977C761FD3B08FD

15 October 2017

1 reference